{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:20:20Z","timestamp":1777983620237,"version":"3.51.4"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR 220013"],"award-info":[{"award-number":["RR 220013"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA260855"],"award-info":[{"award-number":["R01CA260855"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R01 EB030987"],"award-info":[{"award-number":["R01 EB030987"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Defense Breast Cancer Research 1034 Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09555-5","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T20:32:51Z","timestamp":1768854771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radionuclide-stimulated dynamic therapy induces complementary immunogenic necroptosis and apoptosis cancer cell death pathways"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1455-5125","authenticated-orcid":false,"given":"Christopher","family":"Egbulefu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kvar","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinming","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1138-6976","authenticated-orcid":false,"given":"LeMoyne","family":"Habimana-Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Sudlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezugo","family":"Onejeme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Zheleznyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baogang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Esser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Mixdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0528-5880","authenticated-orcid":false,"given":"Evan","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad","family":"Manion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody","family":"Hongsermeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Gamadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Stallings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0267-1847","authenticated-orcid":false,"given":"Chidube","family":"Alagbaoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7443-2752","authenticated-orcid":false,"given":"Matthew M.","family":"Gubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1590-2341","authenticated-orcid":false,"given":"Robert","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Weilbaecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3133-6717","authenticated-orcid":false,"given":"Samuel","family":"Achilefu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"9555_CR1","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7\u201334 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"9555_CR2","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ijgo.2015.03.015","volume":"131","author":"S Becker","year":"2015","unstructured":"Becker, S. A historic and scientific review of breast cancer: the next global healthcare challenge. Int. J. Gynaecol. Obstet. 131, S36\u2013S39 (2015).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"9555_CR3","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1172\/JCI57152","volume":"121","author":"MJ Higgins","year":"2011","unstructured":"Higgins, M. J. & Baselga, J. Targeted therapies for breast cancer. J. Clin. Invest. 121, 3797\u20133803 (2011).","journal-title":"J. Clin. Invest."},{"key":"9555_CR4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nature20609","volume":"540","author":"K Harper","year":"2016","unstructured":"Harper, K. et al. Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature 540, 588\u2013592 (2016).","journal-title":"Nature"},{"key":"9555_CR5","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1158\/1078-0432.CCR-13-2627","volume":"20","author":"EK Moon","year":"2014","unstructured":"Moon, E. K. et al. Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors. Clin. Cancer Res. 20, 4262\u20134273 (2014).","journal-title":"Clin. Cancer Res."},{"key":"9555_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13045-015-0213-6","volume":"8","author":"T Kohnke","year":"2015","unstructured":"Kohnke, T., Krupka, C., Tischer, J., Knosel, T. & Subklewe, M. Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19\/CD3-bispecific T cell engager antibody blinatumomab. J. Hematol. Oncol. 8, 111 (2015).","journal-title":"J. Hematol. Oncol."},{"key":"9555_CR7","first-page":"2355","volume":"56","author":"CJ Gomer","year":"1996","unstructured":"Gomer, C. J. et al. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Cancer Res. 56, 2355\u20132360 (1996).","journal-title":"Cancer Res."},{"key":"9555_CR8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc1894","volume":"6","author":"AP Castano","year":"2006","unstructured":"Castano, A. P., Mroz, P. & Hamblin, M. R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 6, 535\u2013545 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"9555_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1189\/jlb.0306170","volume":"81","author":"D Foell","year":"2007","unstructured":"Foell, D., Wittkowski, H., Vogl, T. & Roth, J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81, 28\u201337 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"9555_CR10","doi-asserted-by":"crossref","unstructured":"Tanaka, K., Choi, J., Cao, Y. & Stacey, G. Extracellular ATP acts as a damage-associated molecular pattern (DAMP) signal in plants. Front. Plant Sci. 5, 446 (2014).","DOI":"10.3389\/fpls.2014.00446"},{"key":"9555_CR11","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","volume":"17","author":"M Mitsunaga","year":"2011","unstructured":"Mitsunaga, M. et al. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat. Med. 17, 1685\u20131691 (2011).","journal-title":"Nat. Med."},{"key":"9555_CR12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nnano.2015.17","volume":"10","author":"N Kotagiri","year":"2015","unstructured":"Kotagiri, N., Sudlow, G. P., Akers, W. J. & Achilefu, S. Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers. Nat. Nanotechnol. 10, 370\u2013379 (2015).","journal-title":"Nat. Nanotechnol."},{"key":"9555_CR13","doi-asserted-by":"crossref","first-page":"26630","DOI":"10.1021\/acsami.6b10255","volume":"8","author":"A Kamkaew","year":"2016","unstructured":"Kamkaew, A. et al. Cerenkov radiation induced photodynamic therapy using chlorin e6-loaded hollow mesoporous silica nanoparticles. ACS Appl. Mater. Interfaces 8, 26630\u201326637 (2016).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"9555_CR14","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02758-9","volume":"9","author":"N Kotagiri","year":"2018","unstructured":"Kotagiri, N. et al. Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer. Nat. Commun. 9, 275 (2018).","journal-title":"Nat. Commun."},{"key":"9555_CR15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejpb.2017.03.013","volume":"115","author":"X Zang","year":"2017","unstructured":"Zang, X. et al. Nanoparticles for tumor immunotherapy. Eur. J. Pharm. Biopharm. 115, 243\u2013256 (2017).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"9555_CR16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41565-018-0086-2","volume":"13","author":"EC Pratt","year":"2018","unstructured":"Pratt, E. C., Shaffer, T. M., Zhang, Q., Drain, C. M. & Grimm, J. Nanoparticles as multimodal photon transducers of ionizing radiation. Nat. Nanotechnol. 13, 418\u2013426 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"9555_CR17","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.7150\/thno.60757","volume":"11","author":"A Zheleznyak","year":"2021","unstructured":"Zheleznyak, A. et al. Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways. Theranostics 11, 7735\u20137754 (2021).","journal-title":"Theranostics"},{"key":"9555_CR18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","volume":"2","author":"FH Igney","year":"2002","unstructured":"Igney, F. H. & Krammer, P. H. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2, 277\u2013288 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"9555_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jconrel.2021.01.016","volume":"331","author":"H Je","year":"2021","unstructured":"Je, H. et al. Overcoming therapeutic efficiency limitations against TRAIL-resistant tumors using re-sensitizing agent-loaded trimeric TRAIL-presenting nanocages. J. Control. Release 331, 7\u201318 (2021).","journal-title":"J. Control. Release"},{"key":"9555_CR20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro, B. A. & El-Deiry, W. S. Targeting apoptosis in cancer therapy. Nat. Rev. Clin. Oncol. 17, 395\u2013417 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"9555_CR21","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.187.9.1477","volume":"187","author":"D Vercammen","year":"1998","unstructured":"Vercammen, D. et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477\u20131485 (1998).","journal-title":"J. Exp. Med."},{"key":"9555_CR22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/82732","volume":"1","author":"N Holler","year":"2000","unstructured":"Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1, 489\u2013495 (2000).","journal-title":"Nat. Immunol."},{"key":"9555_CR23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41551-020-0528-7","volume":"4","author":"D Shen","year":"2020","unstructured":"Shen, D. et al. Selective imaging of solid tumours via the calcium-dependent high-affinity binding of a cyclic octapeptide to phosphorylated Annexin A2. Nat. Biomed. Eng. 4, 298\u2013313 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"9555_CR24","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1097\/RLU.0b013e318279f0d9","volume":"38","author":"Y Shimada","year":"2013","unstructured":"Shimada, Y. et al. Glucose transporter 3 and 1 may facilitate high uptake of 18F-FDG in gastric schwannoma. Clin. Nucl. Med. 38, e417\u2013e420 (2013).","journal-title":"Clin. Nucl. Med."},{"key":"9555_CR25","first-page":"805","volume":"32","author":"V Klenerova","year":"2011","unstructured":"Klenerova, V. et al. Expression of heart oxytocin receptor and its mRNA in two rat strains with different activity of HPA axis. Neuroendocrinol. Lett. 32, 805\u2013810 (2011).","journal-title":"Neuroendocrinol. Lett."},{"key":"9555_CR26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","volume":"15","author":"C Reily","year":"2019","unstructured":"Reily, C., Stewart, T. J., Renfrow, M. B. & Novak, J. Glycosylation in health and disease. Nat. Rev. Nephrol. 15, 346\u2013366 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"9555_CR27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbagen.2011.09.009","volume":"1820","author":"KM Mayle","year":"2012","unstructured":"Mayle, K. M., Le, A. M. & Kamei, D. T. The intracellular trafficking pathway of transferrin. Biochim. Biophys. Acta. 1820, 264\u2013281 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"9555_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1475-2867-11-27","volume":"11","author":"M Wiranowska","year":"2011","unstructured":"Wiranowska, M., Colina, L. O. & Johnson, J. O. Clathrin-mediated entry and cellular localization of chlorotoxin in human glioma. Cancer Cell Int. 11, 27\u201327 (2011).","journal-title":"Cancer Cell Int."},{"key":"9555_CR29","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/smll.200801458","volume":"5","author":"KT Thurn","year":"2009","unstructured":"Thurn, K. T. et al. Labeling TiO2 nanoparticles with dyes for optical fluorescence microscopy and determination of TiO2-DNA nanoconjugate stability. Small 5, 1318\u20131325 (2009).","journal-title":"Small"},{"key":"9555_CR30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ajcp\/75.3.355","volume":"75","author":"A Elbadawi","year":"1981","unstructured":"Elbadawi, A., Musto, L. A. & Lilien, O. M. Combined alizarin red-reticulum stain for tissue localization of calcium deposits. Am. J. Clin. Pathol. 75, 355\u2013356 (1981).","journal-title":"Am. J. Clin. Pathol."},{"key":"9555_CR31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tjog.2014.04.011","volume":"53","author":"C-C Cheng","year":"2014","unstructured":"Cheng, C.-C., Chung, C.-A., Su, L.-C., Chien, C.-C. & Cheng, Y.-C. Osteogenic differentiation of placenta-derived multipotent cells in vitro. Taiwan J. Obstet. Gynecol. 53, 187\u2013192 (2014).","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"9555_CR32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1634\/stemcells.2006-0295","volume":"25","author":"ML Yen","year":"2007","unstructured":"Yen, M. L. et al. Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells 25, 125\u2013131 (2007).","journal-title":"Stem Cells"},{"key":"9555_CR33","doi-asserted-by":"crossref","DOI":"10.1186\/1743-8977-6-17","volume":"6","author":"K Bhattacharya","year":"2009","unstructured":"Bhattacharya, K. et al. Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. Part. Fibre Toxicol. 6, 17 (2009).","journal-title":"Part. Fibre Toxicol."},{"key":"9555_CR34","doi-asserted-by":"crossref","first-page":"e0131208","DOI":"10.1371\/journal.pone.0131208","volume":"10","author":"KN Yu","year":"2015","unstructured":"Yu, K. N. et al. Titanium dioxide nanoparticles induce endoplasmic reticulum stress-mediated autophagic cell death via mitochondria-associated endoplasmic reticulum membrane disruption in normal lung cells. PLoS ONE 10, e0131208 (2015).","journal-title":"PLoS ONE"},{"key":"9555_CR35","doi-asserted-by":"crossref","unstructured":"Strober, W. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. 21, A.3B.1\u2013A.3B.2 (1997).","DOI":"10.1002\/0471142735.ima03bs21"},{"key":"9555_CR36","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ajpath.2010.10.029","volume":"178","author":"L Bao","year":"2011","unstructured":"Bao, L. et al. Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model. Am. J. Pathol. 178, 838\u2013852 (2011).","journal-title":"Am. J. Pathol."},{"key":"9555_CR37","volume":"6","author":"Y Rong","year":"2016","unstructured":"Rong, Y. et al. Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2. Sci. Rep. 6, 23824 (2016).","journal-title":"Sci. Rep."},{"key":"9555_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-42357-w","volume":"9","author":"PC Marinello","year":"2019","unstructured":"Marinello, P. C. et al. Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes. Sci. Rep. 9, 5864 (2019).","journal-title":"Sci. Rep."},{"key":"9555_CR39","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.182.5.1545","volume":"182","author":"SJ Martin","year":"1995","unstructured":"Martin, S. J. et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182, 1545\u20131556 (1995).","journal-title":"J. Exp. Med."},{"key":"9555_CR40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/cr.2015.56","volume":"25","author":"G-B Koo","year":"2015","unstructured":"Koo, G.-B. et al. Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res. 25, 707\u2013725 (2015).","journal-title":"Cell Res."},{"key":"9555_CR41","first-page":"5407","volume":"52","author":"T Miyashita","year":"1992","unstructured":"Miyashita, T. & Reed, J. C. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52, 5407\u20135411 (1992).","journal-title":"Cancer Res."},{"key":"9555_CR42","first-page":"3902","volume":"55","author":"C Teixeira","year":"1995","unstructured":"Teixeira, C., Reed, J. C. & Pratt, M. A. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55, 3902\u20133907 (1995).","journal-title":"Cancer Res."},{"key":"9555_CR43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.redox.2017.12.011","volume":"15","author":"Q Chen","year":"2018","unstructured":"Chen, Q. et al. TiO2 nanoparticles cause mitochondrial dysfunction, activate inflammatory responses, and attenuate phagocytosis in macrophages: a proteomic and metabolomic insight. Redox Biol. 15, 266\u2013276 (2018).","journal-title":"Redox Biol."},{"key":"9555_CR44","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","volume":"11","author":"P Vandenabeele","year":"2010","unstructured":"Vandenabeele, P., Galluzzi, L., Vanden Berghe, T. & Kroemer, G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11, 700\u2013714 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9555_CR45","volume":"4","author":"AG Snyder","year":"2019","unstructured":"Snyder, A. G. et al. Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Sci. Immunol. 4, eaaw2004 (2019).","journal-title":"Sci. Immunol."},{"key":"9555_CR46","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/cbic.201500422","volume":"16","author":"T Dong","year":"2015","unstructured":"Dong, T., Liao, D., Liu, X. & Lei, X. Using small molecules to dissect non-apoptotic programmed cell death: necroptosis, ferroptosis, and pyroptosis. Chembiochem 16, 2557\u20132561 (2015).","journal-title":"Chembiochem"},{"key":"9555_CR47","doi-asserted-by":"crossref","first-page":"100712","DOI":"10.1016\/j.drup.2020.100712","volume":"52","author":"N Shahar","year":"2020","unstructured":"Shahar, N. & Larisch, S. Inhibiting the inhibitors: targeting anti-apoptotic proteins in cancer and therapy resistance. Drug Resist. Updat. 52, 100712 (2020).","journal-title":"Drug Resist. Updat."},{"key":"9555_CR48","doi-asserted-by":"crossref","unstructured":"Campbell, K. J. & Tait, S. W. G. Targeting BCL-2 regulated apoptosis in cancer. Open Biol. 8, 180002 (2018).","DOI":"10.1098\/rsob.180002"},{"key":"9555_CR49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/cancers14010190","volume":"14","author":"MAG Barbosa","year":"2022","unstructured":"Barbosa, M. A. G., Xavier, C. P. R., Pereira, R. F., Petrikait\u0117, V. & Vasconcelos, M. H. 3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs. Cancers 14, 190 (2022).","journal-title":"Cancers"},{"key":"9555_CR50","first-page":"519","volume":"67","author":"A Passaniti","year":"1992","unstructured":"Passaniti, A. et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519\u2013528 (1992).","journal-title":"Lab. Invest."},{"key":"9555_CR51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/73187","volume":"6","author":"K Ohashi","year":"2000","unstructured":"Ohashi, K. et al. Sustained survival of human hepatocytes in mice: a model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat. Med. 6, 327\u2013331 (2000).","journal-title":"Nat. Med."},{"key":"9555_CR52","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13898","volume":"7","author":"TA Aguilera","year":"2016","unstructured":"Aguilera, T. A. et al. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nat. Commun. 7, 13898 (2016).","journal-title":"Nat. Commun."},{"key":"9555_CR53","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-09-1624","volume":"15","author":"JD Wolchok","year":"2009","unstructured":"Wolchok, J. D. et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin. Cancer Res. 15, 7412\u20137420 (2009).","journal-title":"Clin. Cancer Res."},{"key":"9555_CR54","doi-asserted-by":"crossref","unstructured":"Yao, Y., Xu, X.-H. & Jin, L. Macrophage polarization in physiological and pathological pregnancy. Front. Immunol. 10, 792 (2019).","DOI":"10.3389\/fimmu.2019.00792"},{"key":"9555_CR55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fmolb.2020.00060","volume":"7","author":"A Hoter","year":"2020","unstructured":"Hoter, A., Rizk, S. & Naim, H. Y. Heat shock protein 60 in hepatocellular carcinoma: insights and perspectives. Front. Mol. Biosci. 7, 60 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"9555_CR56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2005.08.032","volume":"123","author":"SJ Gardai","year":"2005","unstructured":"Gardai, S. J. et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321\u2013334 (2005).","journal-title":"Cell"},{"key":"9555_CR57","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/emboj.2011.497","volume":"31","author":"AD Garg","year":"2012","unstructured":"Garg, A. D. et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J. 31, 1062\u20131079 (2012).","journal-title":"EMBO J."},{"key":"9555_CR58","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","volume":"410","author":"V Shankaran","year":"2001","unstructured":"Shankaran, V. et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107\u20131111 (2001).","journal-title":"Nature"},{"key":"9555_CR59","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature06309","volume":"450","author":"CM Koebel","year":"2007","unstructured":"Koebel, C. M. et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903\u2013907 (2007).","journal-title":"Nature"},{"key":"9555_CR60","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20112738","volume":"209","author":"T O\u2019Sullivan","year":"2012","unstructured":"O\u2019Sullivan, T. et al. Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J. Exp. Med. 209, 1869\u20131882 (2012).","journal-title":"J. Exp. Med."},{"key":"9555_CR61","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1126\/science.1224922","volume":"337","author":"L Senovilla","year":"2012","unstructured":"Senovilla, L. et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 337, 1678\u20131684 (2012).","journal-title":"Science"},{"key":"9555_CR62","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1182\/blood-2012-08-449025","volume":"121","author":"JL Croxford","year":"2013","unstructured":"Croxford, J. L. et al. ATM-dependent spontaneous regression of early Emu-myc-induced murine B-cell leukemia depends on natural killer and T cells. Blood 121, 2512\u20132521 (2013).","journal-title":"Blood"},{"key":"9555_CR63","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev-chembioeng-080615-034446","volume":"7","author":"RH Fang","year":"2016","unstructured":"Fang, R. H. & Zhang, L. Nanoparticle-based modulation of the immune system. Annu. Rev. Chem. Biomol. Eng. 7, 305\u2013326 (2016).","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"9555_CR64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1166\/jbn.2017.2323","volume":"13","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Enhancement of the immune function by titanium dioxide nanorods and their application in cancer immunotherapy. J. Biomed. Nanotechnol. 13, 367\u2013380 (2017).","journal-title":"J. Biomed. Nanotechnol."},{"key":"9555_CR65","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/039139880302600811","volume":"26","author":"G Giavaresi","year":"2003","unstructured":"Giavaresi, G. et al. In vitro biocompatibility of titanium oxide for prosthetic devices nanostructured by low pressure metal-organic chemical vapor deposition. Int. J. Artif. Organs 26, 774\u2013780 (2003).","journal-title":"Int. J. Artif. Organs"},{"key":"9555_CR66","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1016\/j.biomaterials.2004.01.017","volume":"25","author":"G Giavaresi","year":"2004","unstructured":"Giavaresi, G. et al. Histomorphometric, ultrastructural and microhardness evaluation of the osseointegration of a nanostructured titanium oxide coating by metal-organic chemical vapour deposition: an in vivo study. Biomaterials 25, 5583\u20135591 (2004).","journal-title":"Biomaterials"},{"key":"9555_CR67","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4795","volume":"5","author":"JK Jaiswal","year":"2014","unstructured":"Jaiswal, J. K. et al. S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells. Nat. Commun. 5, 3795 (2014).","journal-title":"Nat. Commun."},{"key":"9555_CR68","first-page":"a008797","volume":"4","author":"HD Ryoo","year":"2012","unstructured":"Ryoo, H. D. & Bergmann, A. The role of apoptosis-induced proliferation for regeneration and cancer. Cold Spring Harb. Perspect. Biol. 4, a008797\u2013a008797 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"9555_CR69","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li, Q. & Verma, I. M. NF-\u03baB regulation in the immune system. Nat. Rev. Immunol. 2, 725\u2013734 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"9555_CR70","first-page":"2648","volume":"119","author":"G Darrasse-J\u00e8ze","year":"2009","unstructured":"Darrasse-J\u00e8ze, G. et al. Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. J. Clin. Invest. 119, 2648\u20132662 (2009).","journal-title":"J. Clin. Invest."},{"key":"9555_CR71","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","volume":"181","author":"JI Youn","year":"2008","unstructured":"Youn, J. I., Nagaraj, S., Collazo, M. & Gabrilovich, D. I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791\u20135802 (2008).","journal-title":"J. Immunol."},{"key":"9555_CR72","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.4049\/jimmunol.161.10.5313","volume":"161","author":"V Bronte","year":"1998","unstructured":"Bronte, V. et al. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+\/Gr-1+ cells. J. Immunol. 161, 5313\u20135320 (1998).","journal-title":"J. Immunol."},{"key":"9555_CR73","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1182\/blood-2008-01-136895","volume":"111","author":"Y Sawanobori","year":"2008","unstructured":"Sawanobori, Y. et al. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111, 5457\u20135466 (2008).","journal-title":"Blood"},{"key":"9555_CR74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jlb.60.3.365","volume":"60","author":"LL Xu","year":"1996","unstructured":"Xu, L. L., Warren, M. K., Rose, W. L., Gong, W. & Wang, J. M. Human recombinant monocyte chemotactic protein and other c-c chemokines bind and induce directional migration of dendritic cells in vitro. J. Leukoc. Biol. 60, 365\u2013371 (1996).","journal-title":"J. Leukoc. Biol."},{"key":"9555_CR75","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.4049\/jimmunol.159.3.1404","volume":"159","author":"M Kitamura","year":"1997","unstructured":"Kitamura, M. Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-beta 1. J. Immunol. 159, 1404\u20131411 (1997).","journal-title":"J. Immunol."},{"key":"9555_CR76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1074-7613(00)80307-6","volume":"5","author":"M Arsura","year":"1996","unstructured":"Arsura, M., Wu, M. & Sonenshein, G. E. TGF beta 1 inhibits NF-kappa B\/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity 5, 31\u201340 (1996).","journal-title":"Immunity"},{"key":"9555_CR77","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe, G. C., Schiemann, W. P. & Lodish, H. F. Role of transforming growth factor \u03b2 in human disease. N. Engl. J. Med. 342, 1350\u20131358 (2000).","journal-title":"N. Engl. J. Med."},{"key":"9555_CR78","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1074-7613(03)00296-6","volume":"19","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri, G., Pflanz, S. & Kastelein, R. A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19, 641\u2013644 (2003).","journal-title":"Immunity"},{"key":"9555_CR79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cyto.2015.01.030","volume":"75","author":"L Sun","year":"2015","unstructured":"Sun, L., He, C., Nair, L., Yeung, J. & Egwuagu, C. E. Interleukin 12 (IL-12) family cytokines: role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine 75, 249\u2013255 (2015).","journal-title":"Cytokine"},{"key":"9555_CR80","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.8097338","volume":"260","author":"C Hsieh","year":"1993","unstructured":"Hsieh, C. et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547\u2013549 (1993).","journal-title":"Science"},{"key":"9555_CR81","first-page":"84","volume":"25","author":"SB Dowton","year":"1988","unstructured":"Dowton, S. B. & Colten, H. R. Acute phase reactants in inflammation and infection. Semin. Hematol. 25, 84\u201390 (1988).","journal-title":"Semin. Hematol."},{"key":"9555_CR82","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv098","volume":"2","author":"A Markanday","year":"2015","unstructured":"Markanday, A. Acute phase reactants in infections: evidence-based review and a guide for clinicians. Open Forum Infect. Dis. 2, ofv098\u2013ofv098 (2015).","journal-title":"Open Forum Infect. Dis."},{"key":"9555_CR83","first-page":"317","volume":"115","author":"C Bray","year":"2016","unstructured":"Bray, C. et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. Wis. Med. J. 115, 317\u2013321 (2016).","journal-title":"Wis. Med. J."},{"key":"9555_CR84","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20072713","volume":"206","author":"H Takatori","year":"2009","unstructured":"Takatori, H. et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206, 35\u201341 (2009).","journal-title":"J. Exp. Med."},{"key":"9555_CR85","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann, T. R. & Coffman, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145\u2013173 (1989).","journal-title":"Annu. Rev. Immunol."},{"key":"9555_CR86","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-013-0556-1","volume":"30","author":"M Kobayashi","year":"2013","unstructured":"Kobayashi, M. et al. Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy. Med. Oncol. 30, 556 (2013).","journal-title":"Med. Oncol."},{"key":"9555_CR87","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1158\/0008-5472.698.65.3","volume":"65","author":"RM Moadel","year":"2005","unstructured":"Moadel, R. M. et al. Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose. Cancer Res. 65, 698\u2013702 (2005).","journal-title":"Cancer Res."},{"key":"9555_CR88","first-page":"334","volume":"10","author":"DM Paul","year":"2020","unstructured":"Paul, D. M. et al. A pilot study treatment of malignant tumors using low-dose (18)F-fluorodeoxyglucose ((18)F-FDG). Am. J. Nucl. Med. Mol. Imaging 10, 334\u2013341 (2020).","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"9555_CR89","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1158\/0008-5472.CAN-15-2663","volume":"76","author":"X Su","year":"2016","unstructured":"Su, X. et al. Antagonizing integrin \u03b23 increases immunosuppression in cancer. Cancer Res. 76, 3484\u20133495 (2016).","journal-title":"Cancer Res."},{"key":"9555_CR90","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1088\/0031-9155\/53\/3\/006","volume":"53","author":"G Wang","year":"2008","unstructured":"Wang, G., Fu, L. & Qi, J. Maximum a posteriori reconstruction of the Patlak parametric image from sinograms in dynamic PET. Phys. Med. Biol. 53, 593\u2013604 (2008).","journal-title":"Phys. Med. Biol."},{"key":"9555_CR91","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13139-011-0087-7","volume":"45","author":"C Kim","year":"2011","unstructured":"Kim, C. et al. Comparison of the intraperitoneal, retroorbital and per oral routes for F-18 FDG administration as effective alternatives to intravenous administration in mouse tumor models using small animal PET\/CT studies. Nucl. Med. Mol. Imaging 45, 169\u2013176 (2011).","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"9555_CR92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1634\/theoncologist.13-S2-19","volume":"13","author":"R Pazdur","year":"2008","unstructured":"Pazdur, R. Endpoints for assessing drug activity in clinical trials. Oncologist 13, 19\u201321 (2008).","journal-title":"Oncologist"},{"key":"9555_CR93","unstructured":"Brunstein, J. Interpretation of qPCR curve shapes. Med. Lab. Obs. 47, 38, 40 (2015)."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09555-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09555-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09555-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:04:12Z","timestamp":1771427052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09555-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9555"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09555-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3992212\/v1","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}